Friday 28 November
| 08:00 | Opening Remarks | T Carrel, Berne |
| Plenary Presentations | ||
| 08:05 | Engineering morphogens and materials to guide tissue repair processes | J Hubbell, Lausanne |
| 09:05 | Title to be announced | D Taylor, Minneapolis |
| 10:00 | Coffee Break | |
| Session 1: Cell Therapy for Heart and Lung Regeneration: Basic and Clinical Aspects | ||
| 10:30 | Intramyocardial stem cell therapy for ischemic heart disease: Current experimental and clinical status | G Steinhoff, Rostock |
| 11:30 | Do airways really need stem cells? | A Giangreco, London |
| 12:30 | Lunch | |
| Session 2: Homing and Engraftment of Progenitor Cells | ||
| 13:30 | Cell therapy for lung diseases - the good and the bad | S Janes, London |
| 14:30 | Homing of circulating stem cells and contribution to tissue remodelling | T Braun, Leipzig |
| 15:30 | Coffee Break | |
| Session 3: Concurrent Sessions: | ||
| Session 3a: Novel Approaches for Cardiovascular Regeneration | ||
| 16:00 | Cardiac tissue engineering: a clinical perspective | W Zimmerman, Hamburg |
| 17:00 | Engineering muscle tissue: in vitro and in vivo studies | M-N Giraud, Berne |
| 17:30 | Cell therapy for peripheral vascular disease: from bench to bedside | C Kalka, Berne |
| 18:00 | Controlled angiogenesis by rapid FACS-purification of VEGF-expressing transduced progenitors | A Banfi, Berne |
| Session 3b: Cell Therapy for the Lung | ||
| 16:00 | The pulmonary surfactant system and lung injury models: relating (ultra-)structure and function | M Ochs, Berne |
| 17:00 | Bone marrow derived stem cells in pulmonary fibrosis | A Gazdhar, Berne |
| 17:20 | The impact of human hepatocyte growth factor (hHGF) in bleomycin-induced pulmonary fibrosis | L Knudsen, Berne |
| 17:40 | Human lung parenchyma cells for lung cell therapy | G Karoubi, Berne |
| 18:00 | Endothelial progenitor cells in lung injury | J Hamacher, Berne |
| 19:30 | Congress Dinner |
Saturday 29 November
| Plenary Presentation | ||
| 08:00 | It takes more than cells to make a good lung | E Weibel, Berne |
| Session 4: Clinically Relevant Stem Cell Populations | ||
| 09:00 | Human embryonic stem cell-derived cardiomyocytes for cardiac repair | R Passier, Utrecht |
| 10:00 | Enbryonic stem cells and lung repair | A Bishop, London |
| 11:00 | Coffee Break | |
| Session 5: Angiogenesis in the Heart and Lung | ||
| 11:30 | Circulating progenitor cells and regeneration of the pulmonary vasculature | J Wharton, London |
| 12:30 | Hemodynamic forces as a stimulus for cardiac angiogenesis | S Egginton, Birmingham |
| 13:30 | Closing Remarks | R Schmid, Berne |